81206 Bcr/abl1 gene major bp
Also known as: BCR-ABL major breakpoint, BCR-ABL p210 testing
Molecular analysis to detect BCR-ABL1 fusion with major breakpoint (p210 fusion protein) in chronic myeloid leukemia.
In Plain Language
chronic leukemia gene test; blood cancer translocation detection
Clinical Context
Used to confirm chronic phase chronic myeloid leukemia diagnosis and guide tyrosine kinase inhibitor selection and monitoring.
RVU Information
CPT 81206 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81206?
CPT 81206 (Bcr/abl1 gene major bp) is a Pathology & Lab code. Molecular analysis to detect BCR-ABL1 fusion with major breakpoint (p210 fusion protein) in chronic myeloid leukemia.
Who uses CPT code 81206?
CPT 81206 is used by Hematology, Oncology, Pathology. Used to confirm chronic phase chronic myeloid leukemia diagnosis and guide tyrosine kinase inhibitor selection and monitoring.
When is CPT 81206 used?
Used to confirm chronic phase chronic myeloid leukemia diagnosis and guide tyrosine kinase inhibitor selection and monitoring.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.